Career & Filing History
Every role Suketu Upadhyay has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Suketu Upadhyay serves as EVP & Chief Financial Officer of INCYTE CORP (INCY). Upadhyay has also held reporting roles at VERTEX PHARMACEUTICALS INC / MA (VRTX) and ZIMMER BIOMET HOLDINGS, INC. (ZBH). Upadhyay has reported 13 insider filings with the SEC since 2024. The most recent filing was in May 2026.
Every role Suketu Upadhyay has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
INCYTE CORP (INCY)1 filingVERTEX PHARMACEUTICALS INC / MA (VRTX)5 filingsZIMMER BIOMET HOLDINGS, INC. (ZBH)7 filingsUpdated Aug 31, 2026
Suketu Upadhyay is EVP & Chief Financial Officer of INCYTE CORP (INCY). 13 SEC Form 4 filings on record going back to 2024, most recently on 6 May 2026.
Every recent SEC Form 4 transaction Suketu Upadhyay has reported, most recent first.
InsiderAlpha's records for Suketu Upadhyay go back to 2024: 13 primary Form 4 filings, an average of 4.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Suketu Upadhyay files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Suketu Upadhyay is a corporate insider, tracked as EVP & Chief Financial Officer of INCYTE CORP (INCY). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
The most recent primary Form 4 on record is dated 6 May 2026, one of 13 filings going back to 2024.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$ZBH ZIMMER BIOMET HOLDINGS, INC.2.0K shares @ $92.54$188K